Precisionsmedicin vid lungcancer – proteiner som nyckel till bättre behandling – Lukas Orres team

Publikationer

Alla gruppmedlemmars publikationer

• Doctoral thesis: 2025

  Harnessing proteomics for precision medicine in lung cancer

  Berkovska O
• Journal article: CANCER RESEARCH. 2025;85(5_Supplement):b026

  Abstract B026: Leveraging patient-derived models to identify novel treatment options in high-grade serous ovarian cancer

  Gudoityte G; Berkovska O; Orre L; Moussaud-Lemoderie E; Fernebro J; Joneborg U; Kallioniemi O; Seashore-Ludlow B
• Article: ISCIENCE. 2025;28(2):111864

  Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer

  Pan Y; Berkovska O; Marathe S; Mermelekas G; Gudoityte G; Wolide AD; Arslan T; Seashore-Ludlow B; Lehtio J; Orre LM
• Article: LEUKEMIA. 2024;38(11):2382-2394

  The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia

  Hagerstrand D; Oder B; Cortese D; Qu Y; Binzer-Panchal A; Osterholm C; Santos TDP; Rabbani L; Asl HF; Skaftason A; Ljungstrom V; Lundholm A; Koutroumani M; Haider Z; Jylha C; Mollstedt J; Mansouri L; Plevova K; Agathangelidis A; Scarfo L; Armand M; Muggen AF; Kay NE; Shanafelt T; Rossi D; Orre LM; Pospisilova S; Barylyuk K; Davi F; Vesterlund M; Langerak AW; Lehtio J; Ghia P; Stamatopoulos K; Sutton L-A; Rosenquist R
• Article: CELL REPORTS MEDICINE. 2024;5(9):101699

  Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma

  Long Jr D; Chan M; Han M; Kamdar Z; Ma RK; Tsai P-Y; Francisco AB; Barrow J; Shackelford DB; Yarchoan M; Mcbride MJ; Orre LM; Vacanti NM; Gujral TS; Sethupathy P
• Article: NPJ PRECISION ONCOLOGY. 2024;8(1):38

  Delineating functional and molecular impact of ex vivo sample handling in precision medicine

  Struyf N; Osterroos A; Vesterlund M; Arnroth C; James T; Sunandar S; Mermelekas G; Bohlin A; Hamberg Levedahl K; Bengtzen S; Jafari R; Orre LM; Lehtio J; Lehmann S; Ostling P; Kallioniemi O; Seashore-Ludlow B; Erkers T
• Article: MOLECULAR CELL. 2023;83(20):3720-3739.e8

  FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress

  Brunner A; Li Q; Fisicaro S; Kourtesakis A; Viiliainen J; Johansson HJ; Pandey V; Mayank AK; Lehtio J; Wohlschlegel JA; Spruck C; Rantala JK; Orre LM; Sangfelt O
• Journal article: ANNALS OF ONCOLOGY. 2023;34:s1163-s1164

  Proteomics-based phenotypic classification of non-smallcell lung cancer

  Berkovska O; Mermelekas G; Orre L; Lehtio J
• Preprint: RESEARCH SQUARE. 2023

  Delineating functional and molecular impact of ex vivo sample handling in precision medicine

  Erkers T; Struyf N; Arnroth C; Vesterlund M; James T; Sunandar S; Bohlin A; Hamberg-Levedahl K; Bengtzén S; Jafari R; Orre L; Lehtiö J; Lehmann S; Ostling P; Kallioniemi O; Seashore-Ludlow B
• Journal article: CANCER RESEARCH. 2023;83(7):6612

  Data-driven hallmarks of cancer as a new paradigm for precision medicine: multi-omics and functional profiling in acute myeloid leukemia

  Erkers T; Struyf N; James T; Marabita F; Vesterlund M; Vu N; Arnroth C; Osterroos A; Bohlin A; Bengtzen S; Stahl M; Jafari R; Orre L; Pawitan Y; Seashore-Ludlow B; Lehtio J; Lehmann S; Ostling P; Kallioniemi O
• Article: NPJ PRECISION ONCOLOGY. 2023;7(1):32

  Prediction model for drug response of acute myeloid leukemia patients

  Trac QT; Pawitan Y; Mou T; Erkers T; Ostling P; Bohlin A; Osterroos A; Vesterlund M; Jafari R; Siavelis I; Backvall H; Kiviluoto S; Orre LM; Rantalainen M; Lehtio J; Lehmann S; Kallioniemi O; Vu TN
• Conference publication: BLOOD. 2022;140:6299

  Data-Driven Molecular Hallmarks of Acute Myeloid Leukemia: Biological, Prognostic and Therapeutic Implications

  Erkers T; Marabita F; Struyf N; Vesterlund M; James T; Arnroth C; Bohlin A; Bengtzen S; Osterroos A; Stahl M; Jafari R; Orre L; Pawitan Y; Seashore-Ludlow B; Lehtio J; Lehmann S; Ostling P; Kallioniemi O
• Article: NATURE PROTOCOLS. 2022;17(8):1832-1867

  SubCellBarCode: integrated workflow for robust spatial proteomics by mass spectrometry

  Arslan T; Pan Y; Mermelekas G; Vesterlund M; Orre LM; Lehtio J
• Preprint: RESEARCH SQUARE. 2021

  Mass spectrometry-based proteomic analysis of NSCLC tumor and biopsy samples

  Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer H; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Asl HF; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Hanson CG; Haakensen VD; Helland Å; Tamborero D; Johansson H; Branca R; Planck M; Staaf J; Orre L
• Preprint: RESEARCH SQUARE. 2021

  STK11 pathway in vitro validation

  Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer H; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Asl HF; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Hanson CG; Haakensen VD; Helland Å; Tamborero D; Johansson H; Branca R; Staaf J; Orre L
• Preprint: RESEARCH SQUARE. 2021

  Immune landscape evaluation of NSCLC clinical samples

  Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer H; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Asl HF; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Hanson CG; Haakensen VD; Helland Å; Tamborero D; Johansson H; Branca R; Planck M; Staaf J; Orre L
• Preprint: RESEARCH SQUARE. 2021

  Bioinformatics analysis of NSCLC multi-omics data

  Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer H; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Asl HF; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Hanson CG; Haakensen VD; Helland Å; Tamborero D; Johansson H; Branca R; Planck M; Staaf J; Orre L
• Article: NATURE CANCER. 2021;2(11):1224-1242

  Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

  Lehtio J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer HM; Mermelekas G; Pirmoradian M; Jonsson M; Brunnstrom H; Brustugun OT; Purohit KP; Cunningham R; Asl HF; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevskaz M; Hansen CG; Haakensen VD; Helland A; Tamborero D; Johansson HJ; Branca RM; Planckz M; Staaf J; Orre LM
• Article: JOURNAL OF EXTRACELLULAR VESICLES. 2021;10(9):e12128

  Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin

  Veerman RE; Teeuwen L; Czarnewski P; Gucluler Akpinar G; Sandberg A; Cao X; Pernemalm M; Orre LM; Gabrielsson S; Eldh M
• Article: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(5):580-588

  The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia

  Mou T; Pawitan Y; Stahl M; Vesterlund M; Deng W; Jafari R; Bohlin A; Osterroos A; Siavelis L; Backvall H; Erkers T; Kiviluoto S; Seashore-Ludlow B; Ostling P; Orre LM; Kallioniemi O; Lehmann S; Lehtio J; Trung NV
• Article: MOLECULAR & CELLULAR PROTEOMICS. 2020;19(6):928-943

  Immediate Adaptation Analysis Implicates BCL6 as an EGFR-TKI Combination Therapy Target in NSCLC

  Tran YZ; Minozada R; Cao X; Johansson HJ; Branca RM; Seashore-Ludlow B; Orre LM
• Article: MOLECULAR & CELLULAR PROTEOMICS. 2020;19(6):1047-1057

  DEqMS: A Method for Accurate Variance Estimation in Differential Protein Expression Analysis

  Zhu Y; Orre LM; Tran YZ; Mermelekas G; Johansson HJ; Malyutina A; Anders S; Lehtio J
• Article: AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. 2020;318(4):L831-L843

  Lung developmental arrest caused by PDGF-A deletion: consequences for the adult mouse lung

  Gouveia L; Kraut S; Hadzic S; Vazquez-Liebanas E; Kojonazarov B; Wu C-Y; Veith C; He L; Mermekkas G; Schermuly RT; Weissmann N; Betsholtz C; Andrae J
• Article: EMBO MOLECULAR MEDICINE. 2020;12(3):e10419

  Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy

  Rudd SG; Tsesmetzis N; Sanjiv K; Paulin CBJ; Sandhow L; Kutzner J; Myrberg IH; Bunten SS; Axelsson H; Zhang SM; Rasti A; Makela P; Coggins SA; Tao S; Suman S; Branca RM; Mermelekas G; Wiita E; Lee S; Walfridsson J; Schinazi RF; Kim B; Lehtio J; Rassidakis GZ; Tamm KP; Warpman-Berglund U; Heyman M; Grander D; Lehmann S; Lundback T; Qian H; Henter J-I; Schaller T; Helleday T; Herold N
• Article: SCIENTIFIC REPORTS. 2020;10(1):3651

  A microparticulate based formulation to protect therapeutic enzymes from proteolytic digestion: phenylalanine ammonia lyase as case study

  de Sousa IP; Gourmel C; Berkovska O; Burger M; Leroux J-C
• Article: MOLECULAR & CELLULAR PROTEOMICS. 2020;19(1):128-141

  The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease

  Haytural H; Mermelekas G; Emre C; Nigam SM; Carroll SL; Winblad B; Bogdanovic N; Barthet G; Granholm A-C; Orre LM; Tjernberg LO; Frykman S
• Article: ONCOGENE. 2019;38(43):6881-6897

  Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors

  Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM
• Article: NATURE COMMUNICATIONS. 2019;10(1):1600

  Breast cancer quantitative proteome and proteogenomic landscape

  Johansson HJ; Socciarelli F; Vacanti NM; Haugen MH; Zhu Y; Siavelis I; Fernandez-Woodbridge A; Aure MR; Sennblad B; Vesterlund M; Branca RM; Orre LM; Huss M; Fredlund E; Beraki E; Garred O; Boekel J; Sauer T; Zhao W; Nord S; Hoglander EK; Jans DC; Brismar H; Haukaas TH; Bathen TF; Schlichting E; Naume B; Geisler J; Hofvind S; Engebraten O; Geitvik GA; Langerod A; Karesen R; Maelandsmo GM; Sorlie T; Skjerven HK; Park D; Hartman-Johnsen O-J; Luders T; Borgen E; Kristensen VN; Russnes HG; Lingjaerde OC; Mills GB; Sahlberg KK; Borresen-Dale A-L; Lehtio J
• Article: MOLECULAR CELL. 2019;73(1):166-182.e7

  SubCellBarCode: Proteome-wide Mapping of Protein Localization and Relocalization

  Orre LM; Vesterlund M; Pan Y; Arslan T; Zhu Y; Woodbridge AF; Frings O; Fredlund E; Lehtio J
• Conference publication: MOLECULAR & CELLULAR PROTEOMICS. 2019;18(8):S40

  Breast cancer quantitative proteome and proteogenomic landscape

  Johansson HJ; Socciarelli F; Vacanti NM; Haugen MH; Zhu Y; Siavelis I; Fernandez-Woodbridge A; Aure MR; Sennblad B; Vesterlund M; Branca RM; Orre LM; Huss M; Fredlund E; Beraki E; Garred O; Boeke J; Sauer T; Zhao W; Nord S; Hoglander EK; Jans DC; Brismar H; Haukaas TH; Bathen TF; Schlichting E; Naume B; Luders T; Borgen E; Kristensen VN; Russnes HG; Lingjaerde OC; Mills GB; Sahlberg KK; Borresen-Dale A-L; Lehtio J
• Article: NATURE BIOTECHNOLOGY. 2018;36(6):521-529

  A protein activity assay to measure global transcription factor activity reveals determinants of chromatin accessibility

  Wei B; Jolma A; Sahu B; Orre LM; Zhong F; Zhu F; Kivioja T; Sur I; Lehtio J; Taipale M; Taipale J
• Corrigendum: NATURE COMMUNICATIONS. 2018;9(1):1852

  Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow (vol 9, 2018)

  Zhu Y; Orre LM; Johansson HJ; Huss M; Boekel J; Vesterlund M; Fernandez-Woodbridge A; Branca RMM; Lehtio J
• Article: NATURE COMMUNICATIONS. 2018;9(1):903

  Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow

  Zhu Y; Orre LM; Johansson HJ; Huss M; Boekel J; Vesterlund M; Fernandez-Woodbridge A; Branca RMM; Lehtio J
• Preprint: BIORXIV. 2017

  Strong binding activity of few transcription factors is a major determinant of open chromatin

  Wei B; Jolma A; Sahu B; Orre LM; Zhong F; Zhu F; Kivioja T; Sur IK; Lehtiö J; Taipale M; Taipale J
• Article: BMC CANCER. 2017;17(1):650

  Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells

  Reithmeier A; Panizza E; Krumpel M; Orre LM; Branca RMM; Lehtio J; Ek-Rylander B; Andersson G
• Article: SCIENTIFIC REPORTS. 2017;7(1):4513

  Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome

  Panizza E; Branca RMM; Oliviusson P; Orre LM; Lehtio J
• Article: ONCOGENE. 2017;36(6):731-745

  microRNAs with AAGUGC seed motif constitute an integral part of an oncogenic signaling network

  Zhou Y; Frings O; Branca RM; Boekel J; le Sage C; Fredlund E; Agami R; Orre LM
• Journal article: CANCER RESEARCH. 2016;76(14_Supplement):1109

  Abstract 1109: AAGUGC-microRNAs are an integral part of an oncogenic signaling network driving non-small cell lung cancer proliferation

  Zhou Y; Frings O; Fredlund E; Boekel J; Branca RM; Orre LM
• Meeting abstract: CANCER RESEARCH. 2016;76:2385

  Understanding the dynamic interplay between genetically different cancer cell clones in glioblastoma

  Guo M; Heller S; Thorslund J; Orre L; Lehtio J; Nister M; Hagerstrand D
• Conference publication: CANCER RESEARCH. 2016;76:3881

  Breast cancer proteogenomics landscape defines subtype specific protein level regulations and reveals proteins coded by pseudogenic loci

  Johansson H; Zhu Y; Haugland M; Sahlberg K; Fredlund E; Huss M; Vacanti N; Aure MR; Sennblad B; Kjellqvist S; Orre L; Lingjaerde OC; Borresen-Dale A-L; Lehtio J
• Article: EXPERIMENTAL CELL RESEARCH. 2015;336(1):158-170

  Secretome protein signature of human gastrointestinal stromal tumor cells

  Berglund E; Dare E; Branca RMM; Akcakaya P; Frobom R; Berggren P-O; Lui W-O; Larsson C; Zedenius J; Orre L; Lehtio J; Kim J; Branstrom R
• Article: MOLECULAR & CELLULAR PROTEOMICS. 2014;13(6):1552-1562

  SpliceVista, a Tool for Splice Variant Identification and Visualization in Shotgun Proteomics Data

  Zhu Y; Hultin-Rosenberg L; Forshed J; Branca RMM; Orre LM; Lehtio J
• Article: NATURE METHODS. 2014;11(1):59-62

  HiRIEF LC-MSMS enables deep proteome coverage and unbiased proteogenomics

  Branca RMM; Orre LM; Johansson HJ; Granholm V; Huss M; Perez-Bercoff A; Forshed J; Kall L; Lehtio J
• Article: ONCOGENE. 2013;32(49):5531-5540

  S100A4 interacts with p53 in the nucleus and promotes p53 degradation

  Orre LM; Panizza E; Kaminskyy VO; Vernet E; Graslund T; Zhivotovsky B; Lehtio J
• Conference publication: CANCER RESEARCH. 2013;73(8):833

  S100A4 interacts with p53 in the nucleus promoting its degradation.

  Orre L; Panizza E; Kaminskyy V; Graslund T; Zhivotovsky B; Lehtio J
• Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2011;47:S78

  Cancer Proteomics - From low Resolution to High Resolution to Study Lung Cancer Phenotype

  Lehtio J; De Petris L; Pernemalm M; Forshed J; Branca R; Orre LM
• Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2011;6(6):S304

  MICRORNAS IN LUNG CANCER A FUNCTIONAL GENOMICS APPROACH FOR DISCOVERY AND VALIDATION OF NOVEL FACTORS DETERMINING RESPONSE TO TREATMENT WITH EGFR-INHIBITORS.

  Orre LM; Le Sage C; Agami R; Lehtio J
• Article: THYROID. 2010;20(10):1067-1076

  Proteomic Study of Thyroid Tumors Reveals Frequent Up-Regulation of the Ca²⁺-Binding Protein S100A6 in Papillary Thyroid Carcinoma

  Sofiadis A; Dinets A; Orre LM; Branca RM; Juhlin CC; Foukakis T; Wallin G; Hoog A; Hulchiy M; Zedenius J; Larsson C; Lehtio J
• Article: PROTEOME SCIENCE. 2010;8:9

  A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants

  De Petris L; Pernemalm M; Elmberger G; Bergman P; Orre L; Lewensohn R; Lehtio J
• Article: PROTEOME SCIENCE. 2009;7:43

  A comparison between protein profiles of B cell subpopulations and mantle cell lymphoma cells

  Stranneheim H; Orre LM; Lehtio J; Flygare J
• Article: LUNG CANCER. 2009;63(3):410-417

  Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer

  De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtio J
• Conference publication: CANCER RESEARCH. 2009;69

  Proteomic studies in well differentiated thyroid tumors

  Sofiadis A; Zedenius J; Wallin G; Foukakis T; Hoog A; Orre L; Lehtio J; Larsson C
• Article: PROTEOMICS. 2008;8(15):3008-3018

  Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms

  Eriksson H; Lengqvist J; Hedlund J; Uhlen K; Orre LM; Bjellqvist B; Persson B; Lehtio J; Jakobsson P-J
• Article: JOURNAL OF PROTEOME RESEARCH. 2008;7(7):2712-2722

  Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery

  Pernemalm M; Orre LM; Lengqvist J; Wikstrom P; Lewensohn R; Lehtio J
• Doctoral thesis: 2008

  Proteomic analysis of DNA damage induced stress signaling with focus on p53 : S100A6 regulation, function and potential as biomarker in lung cancer and as a novel therapeutic target

  Orre L
• Conference publication: ANTICANCER RESEARCH. 2008;28(5C):3275-3276

  QUANTITATIVE MEMBRANE PROTEOMICS APPLYING NARROW RANGE PEPTIDE ISOELECTRIC FOCUSING FOR STUDIES OF SMALL CELL LUNG CANCER RESISTANCE MECHANISMS

  Eriksson H; Lengqvist J; Hedlund J; Uhlen K; Orre LM; Bjellqvist B; Persson B; Lehtio J; Jakobsson P-J
• Conference publication: ANTICANCER RESEARCH. 2008;28(5C):3430-3431

  FUNCTIONAL STUDIES OF S100A6 USING PROTEOMICS

  Orre LM; Vernet E; Lengvist J; Graslund T; Lewensohn R; Lehtio J
• Article: MOLECULAR & CELLULAR PROTEOMICS. 2007;6(12):2122-2131

  Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling

  Orre LM; Pernemalm M; Lengqvist J; Lewensohn R; Lehtio J
• Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006;342(4):1211-1217

  p53 is involved in clearance of ionizing radiation-induced RAD51 foci in a human colon cancer cell line

  Orre LM; Stenerlöw B; Dhar S; Larsson R; Lewensohn R; Lehtiö J
• Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006;341(2):334-342

  Rad51-related changes in global gene expression

  Orre LM; Fält S; Szeles A; Lewensohn R; Wennborg A; Flygare J
• Journal article: BLOOD. 2005;106(11):2367

  Detection of Proteins Related to Therapeutic Outcome, Including Drug Resistance, in Acute Myeloid Leukemia Using Mass Spectrometry and Gel Based Proteomic Profiling.

  Stenke L; Orre L; Dhar S; Larsson R; Lewensohn R; Lehtiö J
• Conference publication: BLOOD. 2005;106(11):666A

  Detection of proteins related to therapeutic outcome, including drug resistance, in acute myeloid leukemia using mass spectrometry and gel based proteomic profiling.

  Stenke L; Orre L; Dhar S; Larsson R; Lewensohn R; Lehtiö J
• Conference publication: MOLECULAR & CELLULAR PROTEOMICS. 2004;3(10):S35

  Detection of proteins related to doxorubicin resistance in myeloma and leukemia using mass Spectrometry-based proteomic profiling

  Orre L; Dhar S; Lewensohn R; Stenke L; Larsson R; Lehtioe J
• Visa fler

Medarbetare och kontakt

Gruppledare

• 

  Lukas Orre

  Senior Forskare | Docent

  E-postadress lukas.orre@ki.se

Alla medarbetare i gruppen

• 

  Olena Berkovska

  Doktorand

  E-postadress olena.berkovska@ki.se
• George Field

  Doktorand

  E-postadress george.field@ki.se
• Georgios Mermelekas

  Senior Forskningsinfrastrukturspecialist

  E-postadress georgios.mermelekas@ki.se
• 

  Lukas Orre

  Senior Forskare | Docent

  E-postadress lukas.orre@ki.se